By MIKE STOBBE, AP Medical Author
NEW YORK (AP) — An skilled panel backed a second COVID-19 vaccine possibility for youths ages 6 to 17 Thursday.
Advisers to the U.S. Facilities for Illness Management and Prevention voted unanimously to advocate Moderna pictures as an possibility for school-age children and adolescents. This group has been in a position to get pictures pictures made by Pfizer since final 12 months.
The panel’s suggestions often are adopted by the CDC, and develop into the federal government’s steering for U.S. medical doctors and their sufferers.
Final week, the Meals and Drug Administration approved the pictures — full-strength doses for kids ages 12 to 17 and half-strength for these 6 to 11. The doses are to be given a few month aside.
The FDA additionally approved a 3rd dose for youths with considerably weakened immune methods, to be given a few month after the second dose of the first sequence. The CDC is anticipated to advocate the identical factor.
Moderna officers have mentioned they anticipate to later provide a booster to all children ages 6 to 17.
How a lot demand there shall be for the pictures isn’t clear. Teenagers grew to become eligible a 12 months in the past for Pfizer’s vaccine, which makes use of the identical expertise, and solely 60% have gotten two doses. Pictures for youthful children began in November; about 29% have been totally vaccinated, in keeping with the CDC.
Greater than 600 COVID-19 deaths have been reported in children ages 5 to 17 within the U.S. Well being officers even have voiced concern concerning the elevated threat of long-lasting well being issues in kids after an infection, resembling diabetes or issues with scent or style.
The Related Press Well being and Science Division receives assist from the Howard Hughes Medical Institute’s Division of Science Schooling. The AP is solely liable for all content material.
Copyright 2022 The Associated Press. All rights reserved. This materials is probably not printed, broadcast, rewritten or redistributed.